Behçet’s refractory uveitis treated successfully by infliximab.

Authors

  • Mahfoudhi Madiha
  • Hariz Anis
  • Ben Abdelghani Khaoula
  • Turki Sami
  • Kheder Adel

Downloads

Download data is not yet available.

References

MH. Houman, M.Khanfir, K.Hamzaoui. Traitements actuels et perspectives thérapeutiques dans la maladie de Behçet. Presse Med 2008; 37: e25-e35.

H. Tanaka, S. Sugita, Y. Yamada et al. Effects and safety of infliximab administration in refractory uveoretinitis with Behçet's disease.Nippon Ganka Ganka Gankkai Zasshi. 2010; 114(2): 87-95.

Y.Yamada, S. Sugita, H.Tanaka, K.Kamoi, T.Kawaguchi, M.Mochizuki. Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease. Br J Ophtalmol 2010; 94 (3): 284-8.

L.Niccoli, C.Nannini, M.Benucci et al. Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study.Rheumatology (Oxford).2007 Jul;46(7):1161-4.

Downloads

Published

2014-02-25

Issue

Section

brief case reports